BOSHOFF CHRISTOFFEL 4
4 · PFIZER INC · Filed Feb 2, 2026
Research Summary
AI-generated summary of this filing
Pfizer (PFE) President R&D Christoffel Boshoff Withholds 12,887 Shares
What Happened
Christoffel Boshoff, President, Research & Development at Pfizer, had 12,887 restricted stock units withheld to satisfy tax obligations upon vesting. The filing shows the shares were disposed at a per-share value of $26.44, for a total value of $340,732. This is a routine tax-withholding disposition (transaction code F), not an open-market sale or purchase.
Key Details
- Transaction date: 2026-01-30; reported on Form 4 filed 2026-02-02.
- Price per share: $26.44; Total value of shares withheld: $340,732.
- Shares owned after transaction: Not specified in the filing.
- Footnote: F1 — shares were withheld to satisfy tax obligations upon RSU vesting (includes dividend equivalents).
- Timeliness: Filed 2026-02-02; no late filing flag indicated in the provided data.
Context
Withholding shares to cover taxes on vested RSUs is a common administrative action and is generally not a directional signal about the insider’s view of the company. This was a tax withholding (cashless) disposition rather than an open-market sale.
Insider Transaction Report
Form 4
PFIZER INCPFE
BOSHOFF CHRISTOFFEL
President, R&D
Transactions
- Tax Payment
Common Stock
[F1]2026-01-30$26.44/sh−12,887$340,732→ 155,645 total
Holdings
- 698(indirect: By Rule 16b-3 Plan)
Common Stock
Footnotes (1)
- [F1]The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon).
Signature
/s/ Shanice A. Reid, by power of atty, for Christoffel Boshoff|2026-02-02